Rabbit antithymocyte globulin induces rapid expansion of effector memory CD8 T cells without accelerating acute graft versus host disease

Leukemia Research Reports

Volumn 2, Issue 2, 2013, Pages 82-85

  Wittenbecher, Friedrich ^a   Rieger, Kathrin ^a   Dziubianau, Mikalai ^a   Herholz, Anne ^a   Mensen, Angela ^a   Blau, Igor Wolfgang ^a   Uharek, Lutz ^a   Dörken, Bernd ^a,b   Thiel, Andreas ^a   Na, Il Kang ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Experimental and Clinical Research Center ECRC   (Germany)

Author keywords

Antithymocyte globulin; CD8 T cell; Effector memory; HSCT; Naive

Indexed keywords

AMSACRINE; ARABINOSIDE; CD45RA ANTIGEN; CHEMOKINE RECEPTOR CCR7; CYCLOPHOSPHAMIDE; CYTOSINE; FLUDARABINE; MITOXANTRONE; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CD3+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; EFFECTOR CELL; FEMALE; FLOW CYTOMETRY; HUMAN; INCIDENCE; LYMPHOCYTE PROLIFERATION; MALE; MEMORY T LYMPHOCYTE; MYELOABLATIVE CONDITIONING; PRIORITY JOURNAL; T CELL DEPLETION; WHOLE BODY RADIATION;

EID: 84887950065     PISSN: 22130489     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lrr.2013.09.001     Document Type: Article

References (11)

1. Na IK, Wittenbecher F, Dziubianau M, Herholz A, Mensen A, Kunkel D, et al. Rabbit antithymocyte globulin (Thymoglobulin(R)) impairs the thymic output of both conventional and regulatory CD4+ T cells after allogeneic hematopoietic stem cell transplantation in adult patients. Haematologica 2013;98(1):23-30.
2. Mueller T. Mechanisms of action of thymoglobulin. Transplantation 2007, 84:S5-S10.
3. Krenger W, Blazar BR, Hollander GA. Thymic T-cell development in allogeneic stem cell transplantation. Blood 2011;117:6768-76.
4. Sallusto F., Lenig D., Forster R., Lipp M., Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999, 401:708-712.
5. Waller E.K., Langston A.A., Lonial S., Cherry J., Somani J., Allen A.J., et al. Pharmacokinetics and pharmacodynamics of anti-thymocyte globulin in recipients of partially HLA-matched blood hematopoietic progenitor cell transplantation. Biology of Blood and Marrow Transplantation 2003, 9:460-471.
6. Geginat J., Lanzavecchia A., Sallusto F. Proliferation and differentiation potential of human CD8+ memory T-cell subsets in response to antigen or homeostatic cytokines. Blood 2003, 101:4260-4266.
7. Theurich S, Fischmann H, Shimabukuro-Vornhagen A, Chemnitz JM, Holtick U, Scheid C, et al. Polyclonal anti-thymocyte globulins for the prophylaxis of graft-versus-host disease after allogeneic stem cell or bone marrow transplantation in adults. Cochrane Database System Review 2012;9:CD009159.
8. Dutt S, Baker J, Kohrt HE, Kambham N, Sanyal M, Negrin RS, et al. CD8+CD44(hi) but not CD4+CD44(hi) memory T cells mediate potent graft antilymphoma activity without GVHD. Blood 2011;117:3230-9.
9. Zheng H., Matte-Martone C., Jain D., McNiff J., Shlomchik W.D. Central memory CD8+ T cells induce graft-versus-host disease and mediate graft-versus-leukemia. Journal of Immunology 2009, 182:5938-5948.
10. Chen B.J., Cui X., Sempowski G.D., Liu C., Chao N.J. Transfer of allogeneic CD62L-memory T cells without graft-versus-host disease. Blood 2004, 103:1534-1541.
11. Distler E, Bloetz A, Albrecht J, Asdufan S, Hohberger A, Frey M, et al. Alloreactive and leukemia-reactive T cells are preferentially derived from naive precursors in healthy donors: implications for immunotherapy with memory T cells. Haematologica 2011;96:1024-32.